Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities. (Q54105933)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949859%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

Europe PubMed Central

Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: current status and therapeutic possibilities (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949859%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

0 references

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

N C Turner

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949859%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

J C Clapham

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949859%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949859%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949859%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949859%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

33-94

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949859%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Role of liver in pathophysiology of NIDDM

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Pathophysiology of insulin resistance in human disease.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Role of insulin resistance in the pathogenesis of NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Insulin resistance is a prominent feature of insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Insulin resistance--mechanisms, syndromes, and implications

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Glucose metabolism in perfused skeletal muscle. Demonstration of insulin resistance in the obese Zucker rat

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Early molecular defects in human insulin resistance: studies in healthy subjects with low insulin sensitivity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Insulin receptor and glucose transporter mRNA expression in skeletal muscle of genetically obese Zucker rats

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effects of altered glucose homeostasis on glucose transporter expression in skeletal muscle of the rat

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Impaired activation of glycogen synthase in people at increased risk for developing NIDDM

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Insulin resistance in skeletal muscles in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Natural history of beta-cell dysfunction in NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Aetiology of obesity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Obesity as a disease

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Science, medicine, and the future. Obesity treatment

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Current views on obesity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Obesity and diabetes: the odd couple

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effect of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non-insulin-dependent) diabetes and on insulin response. The Israel study of glucose intolerance, obesity and hypertension

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Dyslipidaemia and obesity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Relationships of generalized and regional adiposity to insulin sensitivity in men.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Plasma leptin concentrations and OB gene expression in subcutaneous adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Differences in lipolysis between human subcutaneous and omental adipose tissues

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effects of exercise training on abdominal obesity and related metabolic complications

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Leptin and the regulation of body weight

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Obesity and diabetes and the beta-3 adrenergic receptor

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Energy balance: role of genetics and activity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Control of hepatic gluconeogenesis: role of fatty acid oxidation

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Mechanisms of fatty acid-induced inhibition of glucose uptake

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Glucose toxicity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Development of insulin resistance in normal dogs following alloxan-induced insulin deficiency

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

New insights into the metabolic regulation of insulin action and insulin resistance: role of glucose and amino acids.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effects of adrenalectomy before weaning and short- or long-term glucocorticoid administration on the genetically obese Zucker rat.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effects of prednisolone and dexamethasone in vivo and in vitro: studies of insulin binding, deoxyglucose uptake and glucose oxidation in rat adipocytes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

The effects of acute and chronic dexamethasone administration on insulin binding to isolated rat hepatocytes and adipocytes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

The effects of cortisol on insulin sensitivity in muscle.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Possible role for the glucose-fatty acid cycle in dexamethasone-induced insulin antagonism in rats

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Regional adiposity and morbidity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Cortisol secretion in relation to body fat distribution in obese premenopausal women

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Evidence for an autosomal recessive gene regulating the persistence of the insulin response to glucose in man.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Transcribing diabetes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Maternally inherited diabetes and deafness: a new diabetes subtype

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Insulin receptor substrate-1 variants in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Non-linkage of the glucagon-like peptide 1 receptor gene with maturity onset diabetes of the young

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Linkage studies in NIDDM with markers near the sulphonylurea receptor gene

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Diabetic nephropathy. Metabolic versus hemodynamic considerations

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Pathogenesis of diabetic microangiopathy. The hemodynamic view

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Novel thiazolidine-2,4-diones as potent euglycemic agents

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

[[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Troglitazone (CS-045): a new antidiabetic agent

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Pioglitazone treatment for 7 days failed to correct the defect in glucose transport and glucose transporter translocation in obese Zucker rat (fa/fa) skeletal muscle plasma membranes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Peroxisome proliferator-activated receptors A link between endocrinology and nutrition?

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

A pilot clinical trial of a new oral hypoglycemic agent, CS-045, in patients with non-insulin dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Increase of lipoprotein (a) with troglitazone

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Physiological importance of dehydroepiandrosterone

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Chronic administration of dehydroepiandrosterone reduces pancreatic beta-cell hyperplasia and hyperinsulinemia in genetically obese Zucker rats.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Dehydroepiandrosterone in morbidly obese adolescents: effects on weight, body composition, lipids, and insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Adrenal androgens, insulin resistance, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Case report: amelioration of insulin resistance in diabetes with dehydroepiandrosterone.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

GH inhibition of lipogenesis and stimulation of lipolysis in sheep adipose tissue: involvement of protein serine phosphorylation and dephosphorylation and phospholipase C

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Thermogenic effects of the antiglucocorticoid RU-486 in the rat: involvement of corticotropin-releasing factor and sympathetic activation of brown adipose tissue

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

AMP deaminase binding in contracting rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

RU-486 (Mifepristone) ameliorates diabetes but does not correct deficient beta-adrenergic signalling in adipocytes from mature C57BL/6J-ob/ob mice

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Glucocorticoid antagonists

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Through thick and thin: wasting, obesity, and TNF alpha

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Leptin: the tale of an obesity gene

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Two tumour necrosis factor receptors: structure and function.

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

The metabolic effects of tumor necrosis factor and other cytokines

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Pharmacological and clinical studies of ephedrine and other thermogenic agonists

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

The pharmacologic approach to the treatment of obesity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Drug therapy for obesity in the elderly

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Update on the pharmacotherapy of obesity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Valvular heart disease associated with fenfluramine-phentermine

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Sibutramine: a novel new agent for obesity treatment

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

News from the interface: the molecular structures of triacylglyceride lipases

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

The rat lipolytic β-adrenoceptor: Studies using novel β-adrenoceptor agonists

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Molecular characterization of the human beta 3-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Clinical pharmacology of beta 3-adrenoceptors

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Congenital leptin deficiency is associated with severe early-onset obesity in humans

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Leptin: genes, concepts and clinical perspective

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Leptin: its role in obesity and beyond

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Leptin enters the brain by a saturable system independent of insulin

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Crystal structure of the obese protein leptin-E100

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Linkage Between Markers in the Vicinity of the Uncoupling Protein 2 Gene and Resting Metabolic Rate in Humans

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Skeletal muscle metabolism is a major determinant of resting energy expenditure

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

The human uncoupling protein-3 gene. Genomic structure, chromosomal localization, and genetic basis for short and long form transcripts

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Contribution of mitochondrial proton leak to skeletal muscle respiration and to standard metabolic rate

1 reference

https://api.crossref.org/works/10.1007%2F978-3-0348-8845-5_2

31 March 2020

Identifiers

10.1007/978-3-0348-8845-5_2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949859%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9949859%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54105933&oldid=1538956528"